Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Stellate Ganglion Block on IMA Dynamics
NCT05952011Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in coronary artery disease (CAD) (2 arms), sponsored by Ain Shams University. Primary endpoint: Left Internal Mammary Artery Blood Flow. Started Aug 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05952011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05952011.